Article(id=1330233715223016446, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.02.005, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1683216000000, receivedDateStr=2023-05-05, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795082032256, onlineDateStr=2026-11-19, pubDate=1707494400000, pubDateStr=2024-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795082032256, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795082032256, creator=13701087609, updateTime=1795082032256, updator=13701087609, issue=Issue{id=1330233670775976505, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='2', pageStart='165', pageEnd='308', issueExtLink='null', onlineDate='null', pubDate='1707494400000', pubDateStr='2024-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795082021659, creator='13701087609', updateTime=1795082707094, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330236546143334510, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330236546143334511, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330233670775976505, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=203, endPage=209, ext={EN=ArticleExt(id=1330233715415954431, articleId=1330233715223016446, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Research Progress on Detection Methods for Amorphous Content in Active Pharmaceutical Ingredients and Excipients of Inhalation Preparations, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

In recent years, with the frequent occurrence of respiratory diseases such as chronic obstructive pulmonary disease and asthma, pulmonary administration has gradually become a new trend in the treatment of these diseases. And inhalation administration is one of the more widely used ways. In the development of inhalation, there is often a certain amount of amorphous material present in the active pharmaceutical ingredients, excipients, and intermediates due to the processes such as micronization and grinding. Amorphous material has poor thermal stability and can easily transform into the crystalline under certain conditions, which can potentially cause many issues, such as affecting the stability of the final products. Therefore, whether it is a single compound or an intermediate obtained according to a prescription, a mature drug development process must include the detection and quantitative analysis of amorphous material in the drug. This review mainly elaborates on the detection methods commonly used in the pharmaceutical field for the amorphous content.

, authors=Jing XIA1, 2, 3, Yulan YANG2, Xiaodong CHEN2, Xiaofei WANG2, *, authorsList=Jing XIA, Yulan YANG, Xiaodong CHEN, Xiaofei WANG, authorCompany=null, correspAuthors=Xiaofei WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330233715655029760, articleId=1330233715223016446, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=吸入制剂原辅料中无定型物含量检测方法的研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

近年来,随着慢性阻塞性肺疾病、哮喘等呼吸系统疾病的多发,肺部给药逐渐成为治疗这些疾病的新趋势,而吸入给药是其中一种应用较多的途径。在吸入制剂的研发过程中,通常会因为微粉化、研磨等工艺而使原料药、辅料和中间体中存在一定量的无定型态物质。无定型态物质的热稳定性较差,在一定条件下容易转变成晶态物质,很可能会引发许多潜在的问题,比如影响最终产品的稳定性等。因此,无论是单一化合物还是依据处方得到的中间体,成熟的药品研发过程必须包括药物中无定型物的检测和定量分析。文章主要对药学领域中无定型物含量的常用检测方法进行系统阐述。

, authors=夏菁1, 2, 3, 杨玉兰2, 陈晓东2, 王晓飞2, *, authorsList=夏菁, 杨玉兰, 陈晓东, 王晓飞, authorCompany=null, correspAuthors=王晓飞, authorNote=

夏菁(1999—),女,硕士研究生,专业方向:新型制剂研究。

, correspAuthorsNote=
王晓飞(1982—),男,高级工程师,博士硕士生导师,从事吸入制剂等复杂制剂的研究与开发。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=Ar6OcKB2uONCOWB7vArOXw==, magXml=61ic+gqG70OC6r2vM2Xp3g==, pdfUrl=null, pdf=29/CEhZToxkY5H0/yta+7Q==, pdfFileSize=1657873, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=6xEqKgsGm3zg8MT8XaPqmw==, mapNumber=null, fund=null)}, authors=[Author(id=1330233716095430666, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233716187705358, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716095430666, language=EN, stringName=Jing XIA, firstName=Jing, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004
2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203
3.Yangtze Delta Drug Advance Research Institute, Nantong 226133, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233716259008527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716095430666, language=CN, stringName=夏菁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.江西中医药大学药学院,江西 南昌 330004
2.上海欧米尼医药科技有限公司,上海 201203
3.南通市海门长三角药物高等研究院,江苏 南通 226133, bio={"content":"

夏菁(1999—),女,硕士研究生,专业方向:新型制剂研究。

"}, bioImg=null, bioContent=

夏菁(1999—),女,硕士研究生,专业方向:新型制剂研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233715847966720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=1., ext=[AuthorCompanyExt(id=1330233715856355329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715847966720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004), AuthorCompanyExt(id=1330233715864743938, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715847966720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.江西中医药大学药学院,江西 南昌 330004)]), AuthorCompany(id=1330233715923464195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=2., ext=[AuthorCompanyExt(id=1330233715931852804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1330233715940241413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海欧米尼医药科技有限公司,上海 201203)]), AuthorCompany(id=1330233716003155974, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=3., ext=[AuthorCompanyExt(id=1330233716011544583, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233716003155974, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Yangtze Delta Drug Advance Research Institute, Nantong 226133), AuthorCompanyExt(id=1330233716019933192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233716003155974, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.南通市海门长三角药物高等研究院,江苏 南通 226133)])]), Author(id=1330233716326117393, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233716418392083, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716326117393, language=EN, stringName=Yulan YANG, firstName=Yulan, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233716481306644, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716326117393, language=CN, stringName=杨玉兰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海欧米尼医药科技有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233715923464195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=2., ext=[AuthorCompanyExt(id=1330233715931852804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1330233715940241413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海欧米尼医药科技有限公司,上海 201203)])]), Author(id=1330233716573581334, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233716661661720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716573581334, language=EN, stringName=Xiaodong CHEN, firstName=Xiaodong, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233716724576281, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716573581334, language=CN, stringName=陈晓东, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海欧米尼医药科技有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233715923464195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=2., ext=[AuthorCompanyExt(id=1330233715931852804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1330233715940241413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海欧米尼医药科技有限公司,上海 201203)])]), Author(id=1330233716787490843, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xfwang@omni-pharma.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233716871376925, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716787490843, language=EN, stringName=Xiaofei WANG, firstName=Xiaofei, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233716934291486, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716787490843, language=CN, stringName=王晓飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海欧米尼医药科技有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233715923464195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=2., ext=[AuthorCompanyExt(id=1330233715931852804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1330233715940241413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海欧米尼医药科技有限公司,上海 201203)])])], keywords=[Keyword(id=1330233717043343391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, language=EN, orderNo=1, keyword=inhalation preparation), Keyword(id=1330233717106257952, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, language=EN, orderNo=2, keyword=amorphism), Keyword(id=1330233718716870689, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, language=EN, orderNo=3, keyword=content), Keyword(id=1330233718809145378, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, language=EN, orderNo=4, keyword=detection method), Keyword(id=1330233718867865635, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, language=EN, orderNo=5, keyword=quantitative analysis), Keyword(id=1330233718939168804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, language=CN, orderNo=1, keyword=吸入制剂), Keyword(id=1330233719031443493, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, language=CN, orderNo=2, keyword=无定型), Keyword(id=1330233719132106790, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, language=CN, orderNo=3, keyword=含量), Keyword(id=1330233719249547303, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, language=CN, orderNo=4, keyword=检测方法), Keyword(id=1330233719346016296, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, language=CN, orderNo=5, keyword=定量分析)], refs=[Reference(id=1330233719438290985, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=CIPOLLA D, CHAN H K.Current and emerging inhaled therapies of repositioned drugs [J].Adv Drug Deliv Rev, 2018, 133: 1-4., articleTitle=null, refAbstract=null), Reference(id=1330233719501205546, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ANSELMO A C, GOKARN Y, MITRAGOTRI S.Non-invasive delivery strategies for biologics [J].Nat Rev Drug Discov, 2018, 18(1): 19-40., articleTitle=null, refAbstract=null), Reference(id=1330233719572508715, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=袁利佳,王健.我国吸入制剂的研发应用现状与监管思考[J].中国医药工业杂志,2022,53(12):1810-1813., articleTitle=null, refAbstract=null), Reference(id=1330233719635423276, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=THAKRAL N K, ZANON R L, THAKRAL S, et al.Applications of powder X-ray diffraction in small molecule pharmaceuticals: achievements and aspirations [J].J Pharm Sci, 2018, 107(12): 2969-2982., articleTitle=null, refAbstract=null), Reference(id=1330233719706726445, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=LI B, HU Y, LU S, et al.Apigenin-oxymatrine binary co-amorphous mixture: enhanced solubility, bioavailability, and anti-inflammatory effect [J].Food Chem, 2022, 373: 131485., articleTitle=null, refAbstract=null), Reference(id=1330233719778029614, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=ALHAJJ N, O'REILLY N J, CATHCART H.Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system [J].Int J Pharm, 2022, 618: 121657., articleTitle=null, refAbstract=null), Reference(id=1330233719845138479, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU J, LI Y, LI S, et al.Preparation and characterization of aprepitant solid dispersion with HPMCAS-LF [J].ACS Omega, 2022, 7(44): 39907-39912., articleTitle=null, refAbstract=null), Reference(id=1330233719908053040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=LAPUK S E, ZUBAIDULLINA L S, GERASIMOV A V,et al.Kinetic stability of amorphous solid dispersions with high content of the drug: a fast scanning calorimetry investigation [J].Int J Pharm, 2019, 562: 113-123., articleTitle=null, refAbstract=null), Reference(id=1330233719987744817, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=ABDUL-JABBAR S, WONG D W, ROYALL P G, et al.Repurposing melt degradation for the evaluation of mixed amorphous-crystalline blends [J].AAPS Pharm Sci Tech, 2021, 22(3): 105., articleTitle=null, refAbstract=null), Reference(id=1330233720046465074, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=TRENFIELD S J, JANUSKAITE P, BASIT A W, et al.Prediction of solid-state form of SLS 3D printed medicines using NIR and Raman spectroscopy [J].Pharmaceutics, 2022, 14(3): 589., articleTitle=null, refAbstract=null), Reference(id=1330233720105185331, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=HEBBINK G A, JASPERS M, DICKHOFF B H J, et al.Recent developments in lactose blend formulations for carrier-based dry powder inhalation [J].Adv Drug Deliv Rev, 2022, 189: 114527., articleTitle=null, refAbstract=null), Reference(id=1330233720163905588, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=DAS S, LARSON I, YOUNG P, et al.Influence of storage relative humidityon the dispersion of salmeterol xinafoate powders for inhalation [J].J Pharm Sci, 2009, 98(3): 1015-1027., articleTitle=null, refAbstract=null), Reference(id=1330233720231014453, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=KE W R, CHANG R Y K, CHAN H K, et al.Spray drying lactose from organic solvent suspensions for aerosol delivery to the lungs [J].Int J Pharm, 2020, 591: 119984., articleTitle=null, refAbstract=null), Reference(id=1330233720298123318, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=TEJEDOR M B, PAZESH S, MILLQVIST-FUREBY A,et al.Milling induced amorphisation and recrystallization of alpha-lactose monohydrate [J].Int J Pharm, 2018, 537(1/2): 140-147., articleTitle=null, refAbstract=null), Reference(id=1330233720356843575, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=AFRASSIABIAN Z, GUESSASMA M, SALEH K.A study on the caking behaviour of binary mixtures of lactose due to solid-state crystallisation of the amorphous phase [J].Chem Eng Res Des, 2019, 147: 354-366., articleTitle=null, refAbstract=null), Reference(id=1330233720419758136, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=BRUNAUGH A, SMYTH H D C.Process optimization and particle engineering of micronized drug powders via milling[J].Drug Deliv Transl Res, 2018, 8(6): 1740-1750., articleTitle=null, refAbstract=null), Reference(id=1330233720482672697, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=张杰,蔡挺.无定型态药物制备技术研究进展[J].药学进展,2018,42(9):41-50., articleTitle=null, refAbstract=null), Reference(id=1330233720541392954, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=SOSNA T, MIKESKA M, PLACHÁ D, et al.Micronization of ibuprofen particles using supercritical fluid technology[J].J Nanosci Nanotechnol, 2019, 19(5): 2814-2820., articleTitle=null, refAbstract=null), Reference(id=1330233720600113211, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=MISRA S K, PATHAK K.Supercritical fluid technology for solubilization of poorly water soluble drugs via micro and naonosized particle generation [J].Admet Dmpk, 2020, 8(4): 355-374., articleTitle=null, refAbstract=null), Reference(id=1330233720667222076, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG Y, MACKENZIE B, WILLIAMS R, et al.Development of an excipient-free peptide dry powder inhalation for the treatment of pulmonary fibrosis [J].Mol Pharm, 2020, 17(2): 632-644., articleTitle=null, refAbstract=null), Reference(id=1330233720725942333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=ADHIKARI B R, DAS S C.Amorphicity and aerosolization of soluplus-based inhalable spray dried powders [J].Pharmaceutics, 2022, 14(12): 2618., articleTitle=null, refAbstract=null), Reference(id=1330233720784662590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Z, CHEN X, HUANG Y, et al.Platensimycin-berberine chloride co-amorphous drug system: sustained release and prolonged half-life [J].Eur J Pharm Biopharm, 2022, 179: 126-136., articleTitle=null, refAbstract=null), Reference(id=1330233720847577151, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=ALEXANDER L, KLUG H P.Basic aspects of X-ray absorption in quantitative diffraction analysis of powder mixtures [J].Anal Chem, 1948, 20(10): 886-889., articleTitle=null, refAbstract=null), Reference(id=1330233720927268928, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=SHETTY N, ZENG L, ZHOU Q T, et al.Effects of moisture-induced crystallization on the aerosol performance of spray dried amorphous ciprofloxacin powder formulations[J].Pharm Res, 2018, 35(1): 7., articleTitle=null, refAbstract=null), Reference(id=1330233720994377793, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=PARTY P, BARTOS C, AMBRUS R, et al.Formulation and in vitro and in silico characterization of "nano-in-micro" dry powder inhalers containing meloxicam [J].Pharmaceutics, 2021, 13(2): 211., articleTitle=null, refAbstract=null), Reference(id=1330233721061486658, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=MOLINA C, KAIALY W, NOKHODCHI A, et al.Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations [J].Drug Deliv Transl Res, 2018, 8(6): 1769-1780., articleTitle=null, refAbstract=null), Reference(id=1330233721128595523, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=GUNASEELAN S, RAO R, SIVAKUMAR B, et al.Determination of traces of amorphous cefuroxime axetil content in cefuroxime axetil crystalline drug substance using modulated differential scanning calorimetry (MDSC)[J].J Chem Pharm Res, 2012, 4(11): 4743-4751., articleTitle=null, refAbstract=null), Reference(id=1330233721195704388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=LU W, RANTANEN J, YANG M, et al. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying [J].Int J Pharm, 2019, 565: 1-8., articleTitle=null, refAbstract=null), Reference(id=1330233721267007557, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=EDUENG K, BERGSTROM C A S, MAHLIN D, et al.Long-term physical (in)stability of spray-dried amorphous drugs: relationship with glass-forming ability and physicochemical properties [J].Pharmaceutics, 2019, 11(9): 1-4., articleTitle=null, refAbstract=null), Reference(id=1330233721317339206, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=EDINGER M, KNOPP M M, LÖBMANN K, et al.Quantification of microwave-induced amorphization of celecoxib in PVP tablets using transmission Raman spectroscopy [J].Eur J Pharm Sci, 2018, 117: 62-67., articleTitle=null, refAbstract=null), Reference(id=1330233721380253767, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=LUEBBERT C, KLANKE C, SADOWSKI G.Investigating phase separation in amorphous solid dispersions via Raman mapping [J].Int J Pharm, 2018, 535(1/2): 245-252., articleTitle=null, refAbstract=null), Reference(id=1330233721443168328, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=KILPELAINEN T, PAJULA K, KORHONEN O, et al.Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems [J].Eur J Pharm Biopharm, 2020, 155: 49-54., articleTitle=null, refAbstract=null), Reference(id=1330233721501888585, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=CALVO N L, MAGGIO R M, KAUFMAN T S.Chemometrics-assisted solid-state characterization of pharmaceutically relevant materials polymorphic substances[J].J Pharm Biomed Anal, 2018, 147: 518-537., articleTitle=null, refAbstract=null), Reference(id=1330233721560608842, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=GAISFORD S.Isothermal microcalorimetry for quantifying amorphous content inprocessed pharmaceuticals [J].Adv Drug Deliver Rev, 2012, 64(5): 431-439., articleTitle=null, refAbstract=null), Reference(id=1330233721627717707, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=ANGBERG M, NYSTROM C, CASTENSSON S.Evaluation of heat-conduction microcalorimetry in pharmaceutical stability studies.Ⅲ.Crystallographic changes due to water vapour uptake in anhydrous lactose powder [J].Int J Pharm, 1991, 73(3): 209-220., articleTitle=null, refAbstract=null), Reference(id=1330233723263496269, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=ANGBERG M, NYSTROM C, CASTENSSON S.Evaluation of heat conduction microcalorimetry in pharmaceutical stability studies.Ⅴ.A new approach for continuous measurements in abundant water vapour [J].Int J Pharm, 1992, 81(2/3): 153-167., articleTitle=null, refAbstract=null), Reference(id=1330233723368353870, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=ANGBERG M, NYSTROM C, CASTENSSON S.Evaluation of heat-conduction microcalorimetry in pharmaceutical stability studies.Ⅵ.Continuous monitoring of the interaction of water vapour with powders and powder mixtures at various relative humidities [J].Int J Pharm, 1992, 83(1/3): 11-23., articleTitle=null, refAbstract=null), Reference(id=1330233723431268431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=MACKIN L, ZANON R, DEMONTE M, et al.Quantification of low levels (<10%) of amorphous content in micronised active batches using dynamic vapour sorption and isothermal microcalorimetry [J].Int J Pharm, 2002, 231(2): 227-236., articleTitle=null, refAbstract=null), Reference(id=1330233723510960208, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=STANKOVIC-BRANDL M, ZELLNITZ S, PAUDEL A, et al.The influence of relative humidity and storage conditions on the physico-chemical properties of inhalation grade fine lactose [J].AAPS Pharm Sci Tech, 2021, 23(1): 1., articleTitle=null, refAbstract=null), Reference(id=1330233723573874769, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=MÜLLER T, SCHIEWE J, STECKEL H, et al.Measurement of low amounts of amorphous content in hydrophobicactive pharmaceutical ingredients with dynamic organic vapor sorption [J].Eur J Pharm Sci, 2015, 92: 102-111., articleTitle=null, refAbstract=null), Reference(id=1330233723653566546, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=BAGWAN N U, SHEOKAND S, KUMAR A, et al.Role of surface molecular environment and amorphous content in moisture sorption behavior of milled Terbutaline Sulphate[J].Eur J Pharm Sci, 2021, 161: 105782., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330233715847966720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=1., ext=[AuthorCompanyExt(id=1330233715856355329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715847966720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004), AuthorCompanyExt(id=1330233715864743938, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715847966720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.江西中医药大学药学院,江西 南昌 330004)]), AuthorCompany(id=1330233715923464195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=2., ext=[AuthorCompanyExt(id=1330233715931852804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1330233715940241413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海欧米尼医药科技有限公司,上海 201203)]), AuthorCompany(id=1330233716003155974, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=3., ext=[AuthorCompanyExt(id=1330233716011544583, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233716003155974, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Yangtze Delta Drug Advance Research Institute, Nantong 226133), AuthorCompanyExt(id=1330233716019933192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233716003155974, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.南通市海门长三角药物高等研究院,江苏 南通 226133)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.02.005, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.02.005, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.02.005, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.02.005, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1707494400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
吸入制剂原辅料中无定型物含量检测方法的研究进展
夏菁 1, 2, 3 , 杨玉兰 2 , 陈晓东 2 , 王晓飞 2, *
中国医药工业杂志 | 综述 2024,55(2): 203-209
收起
收藏切换
中国医药工业杂志 |综述 2024 , 55 (2) : 203 -209
吸入制剂原辅料中无定型物含量检测方法的研究进展
全屏
[Author(id=1330233716095430666, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233716187705358, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716095430666, language=EN, stringName=Jing XIA, firstName=Jing, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004
2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203
3.Yangtze Delta Drug Advance Research Institute, Nantong 226133, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233716259008527, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716095430666, language=CN, stringName=夏菁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.江西中医药大学药学院,江西 南昌 330004
2.上海欧米尼医药科技有限公司,上海 201203
3.南通市海门长三角药物高等研究院,江苏 南通 226133, bio={"content":"

夏菁(1999—),女,硕士研究生,专业方向:新型制剂研究。

"}, bioImg=null, bioContent=

夏菁(1999—),女,硕士研究生,专业方向:新型制剂研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233715847966720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=1., ext=[AuthorCompanyExt(id=1330233715856355329, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715847966720, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004), AuthorCompanyExt(id=1330233715864743938, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715847966720, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.江西中医药大学药学院,江西 南昌 330004)]), AuthorCompany(id=1330233715923464195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=2., ext=[AuthorCompanyExt(id=1330233715931852804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1330233715940241413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海欧米尼医药科技有限公司,上海 201203)]), AuthorCompany(id=1330233716003155974, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=3., ext=[AuthorCompanyExt(id=1330233716011544583, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233716003155974, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Yangtze Delta Drug Advance Research Institute, Nantong 226133), AuthorCompanyExt(id=1330233716019933192, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233716003155974, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.南通市海门长三角药物高等研究院,江苏 南通 226133)])]), Author(id=1330233716326117393, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233716418392083, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716326117393, language=EN, stringName=Yulan YANG, firstName=Yulan, middleName=null, lastName=YANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233716481306644, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716326117393, language=CN, stringName=杨玉兰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海欧米尼医药科技有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233715923464195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=2., ext=[AuthorCompanyExt(id=1330233715931852804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1330233715940241413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海欧米尼医药科技有限公司,上海 201203)])]), Author(id=1330233716573581334, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330233716661661720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716573581334, language=EN, stringName=Xiaodong CHEN, firstName=Xiaodong, middleName=null, lastName=CHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233716724576281, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716573581334, language=CN, stringName=陈晓东, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.上海欧米尼医药科技有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233715923464195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=2., ext=[AuthorCompanyExt(id=1330233715931852804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1330233715940241413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海欧米尼医药科技有限公司,上海 201203)])]), Author(id=1330233716787490843, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=xfwang@omni-pharma.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330233716871376925, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716787490843, language=EN, stringName=Xiaofei WANG, firstName=Xiaofei, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330233716934291486, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, authorId=1330233716787490843, language=CN, stringName=王晓飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海欧米尼医药科技有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330233715923464195, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, xref=2., ext=[AuthorCompanyExt(id=1330233715931852804, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1330233715940241413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330233715223016446, companyId=1330233715923464195, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海欧米尼医药科技有限公司,上海 201203)])])]
夏菁1, 2, 3, 杨玉兰2, 陈晓东2, 王晓飞2, *
作者信息
  • 1.江西中医药大学药学院,江西 南昌 330004
  • 2.上海欧米尼医药科技有限公司,上海 201203
  • 3.南通市海门长三角药物高等研究院,江苏 南通 226133
通讯作者:
王晓飞(1982—),男,高级工程师,博士硕士生导师,从事吸入制剂等复杂制剂的研究与开发。E-mail:
作者简介:

夏菁(1999—),女,硕士研究生,专业方向:新型制剂研究。

Research Progress on Detection Methods for Amorphous Content in Active Pharmaceutical Ingredients and Excipients of Inhalation Preparations
Jing XIA1, 2, 3, Yulan YANG2, Xiaodong CHEN2, Xiaofei WANG2, *
Affiliations
  • 1.School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004
  • 2.Shanghai Omni Pharmaceutical Co., Ltd., Shanghai 201203
  • 3.Yangtze Delta Drug Advance Research Institute, Nantong 226133
出版时间: 2024-02-10 doi: 10.16522/j.cnki.cjph.2024.02.005
文章导航
收藏切换

近年来,随着慢性阻塞性肺疾病、哮喘等呼吸系统疾病的多发,肺部给药逐渐成为治疗这些疾病的新趋势,而吸入给药是其中一种应用较多的途径。在吸入制剂的研发过程中,通常会因为微粉化、研磨等工艺而使原料药、辅料和中间体中存在一定量的无定型态物质。无定型态物质的热稳定性较差,在一定条件下容易转变成晶态物质,很可能会引发许多潜在的问题,比如影响最终产品的稳定性等。因此,无论是单一化合物还是依据处方得到的中间体,成熟的药品研发过程必须包括药物中无定型物的检测和定量分析。文章主要对药学领域中无定型物含量的常用检测方法进行系统阐述。

吸入制剂  /  无定型  /  含量  /  检测方法  /  定量分析

In recent years, with the frequent occurrence of respiratory diseases such as chronic obstructive pulmonary disease and asthma, pulmonary administration has gradually become a new trend in the treatment of these diseases. And inhalation administration is one of the more widely used ways. In the development of inhalation, there is often a certain amount of amorphous material present in the active pharmaceutical ingredients, excipients, and intermediates due to the processes such as micronization and grinding. Amorphous material has poor thermal stability and can easily transform into the crystalline under certain conditions, which can potentially cause many issues, such as affecting the stability of the final products. Therefore, whether it is a single compound or an intermediate obtained according to a prescription, a mature drug development process must include the detection and quantitative analysis of amorphous material in the drug. This review mainly elaborates on the detection methods commonly used in the pharmaceutical field for the amorphous content.

inhalation preparation  /  amorphism  /  content  /  detection method  /  quantitative analysis
夏菁, 杨玉兰, 陈晓东, 王晓飞. 吸入制剂原辅料中无定型物含量检测方法的研究进展. 中国医药工业杂志, 2024 , 55 (2) : 203 -209 . DOI: 10.16522/j.cnki.cjph.2024.02.005
Jing XIA, Yulan YANG, Xiaodong CHEN, Xiaofei WANG. Research Progress on Detection Methods for Amorphous Content in Active Pharmaceutical Ingredients and Excipients of Inhalation Preparations[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (2) : 203 -209 . DOI: 10.16522/j.cnki.cjph.2024.02.005

参考文献 引证文献
排序方式:
[1]
CIPOLLA D, CHAN H K.Current and emerging inhaled therapies of repositioned drugs [J].Adv Drug Deliv Rev, 2018, 133: 1-4.
[2]
ANSELMO A C, GOKARN Y, MITRAGOTRI S.Non-invasive delivery strategies for biologics [J].Nat Rev Drug Discov, 2018, 18(1): 19-40.
[3]
袁利佳,王健.我国吸入制剂的研发应用现状与监管思考[J].中国医药工业杂志,2022,53(12):1810-1813.
[4]
THAKRAL N K, ZANON R L, THAKRAL S, et al.Applications of powder X-ray diffraction in small molecule pharmaceuticals: achievements and aspirations [J].J Pharm Sci, 2018, 107(12): 2969-2982.
[5]
LI B, HU Y, LU S, et al.Apigenin-oxymatrine binary co-amorphous mixture: enhanced solubility, bioavailability, and anti-inflammatory effect [J].Food Chem, 2022, 373: 131485.
[6]
ALHAJJ N, O'REILLY N J, CATHCART H.Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system [J].Int J Pharm, 2022, 618: 121657.
[7]
LIU J, LI Y, LI S, et al.Preparation and characterization of aprepitant solid dispersion with HPMCAS-LF [J].ACS Omega, 2022, 7(44): 39907-39912.
[8]
LAPUK S E, ZUBAIDULLINA L S, GERASIMOV A V,et al.Kinetic stability of amorphous solid dispersions with high content of the drug: a fast scanning calorimetry investigation [J].Int J Pharm, 2019, 562: 113-123.
[9]
ABDUL-JABBAR S, WONG D W, ROYALL P G, et al.Repurposing melt degradation for the evaluation of mixed amorphous-crystalline blends [J].AAPS Pharm Sci Tech, 2021, 22(3): 105.
[10]
TRENFIELD S J, JANUSKAITE P, BASIT A W, et al.Prediction of solid-state form of SLS 3D printed medicines using NIR and Raman spectroscopy [J].Pharmaceutics, 2022, 14(3): 589.
[11]
HEBBINK G A, JASPERS M, DICKHOFF B H J, et al.Recent developments in lactose blend formulations for carrier-based dry powder inhalation [J].Adv Drug Deliv Rev, 2022, 189: 114527.
[12]
DAS S, LARSON I, YOUNG P, et al.Influence of storage relative humidityon the dispersion of salmeterol xinafoate powders for inhalation [J].J Pharm Sci, 2009, 98(3): 1015-1027.
[13]
KE W R, CHANG R Y K, CHAN H K, et al.Spray drying lactose from organic solvent suspensions for aerosol delivery to the lungs [J].Int J Pharm, 2020, 591: 119984.
[14]
TEJEDOR M B, PAZESH S, MILLQVIST-FUREBY A,et al.Milling induced amorphisation and recrystallization of alpha-lactose monohydrate [J].Int J Pharm, 2018, 537(1/2): 140-147.
[15]
AFRASSIABIAN Z, GUESSASMA M, SALEH K.A study on the caking behaviour of binary mixtures of lactose due to solid-state crystallisation of the amorphous phase [J].Chem Eng Res Des, 2019, 147: 354-366.
[16]
BRUNAUGH A, SMYTH H D C.Process optimization and particle engineering of micronized drug powders via milling[J].Drug Deliv Transl Res, 2018, 8(6): 1740-1750.
[17]
张杰,蔡挺.无定型态药物制备技术研究进展[J].药学进展,2018,42(9):41-50.
[18]
SOSNA T, MIKESKA M, PLACHÁ D, et al.Micronization of ibuprofen particles using supercritical fluid technology[J].J Nanosci Nanotechnol, 2019, 19(5): 2814-2820.
[19]
MISRA S K, PATHAK K.Supercritical fluid technology for solubilization of poorly water soluble drugs via micro and naonosized particle generation [J].Admet Dmpk, 2020, 8(4): 355-374.
[20]
ZHANG Y, MACKENZIE B, WILLIAMS R, et al.Development of an excipient-free peptide dry powder inhalation for the treatment of pulmonary fibrosis [J].Mol Pharm, 2020, 17(2): 632-644.
[21]
ADHIKARI B R, DAS S C.Amorphicity and aerosolization of soluplus-based inhalable spray dried powders [J].Pharmaceutics, 2022, 14(12): 2618.
[22]
WANG Z, CHEN X, HUANG Y, et al.Platensimycin-berberine chloride co-amorphous drug system: sustained release and prolonged half-life [J].Eur J Pharm Biopharm, 2022, 179: 126-136.
[23]
ALEXANDER L, KLUG H P.Basic aspects of X-ray absorption in quantitative diffraction analysis of powder mixtures [J].Anal Chem, 1948, 20(10): 886-889.
[24]
SHETTY N, ZENG L, ZHOU Q T, et al.Effects of moisture-induced crystallization on the aerosol performance of spray dried amorphous ciprofloxacin powder formulations[J].Pharm Res, 2018, 35(1): 7.
[25]
PARTY P, BARTOS C, AMBRUS R, et al.Formulation and in vitro and in silico characterization of "nano-in-micro" dry powder inhalers containing meloxicam [J].Pharmaceutics, 2021, 13(2): 211.
[26]
MOLINA C, KAIALY W, NOKHODCHI A, et al.Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations [J].Drug Deliv Transl Res, 2018, 8(6): 1769-1780.
[27]
GUNASEELAN S, RAO R, SIVAKUMAR B, et al.Determination of traces of amorphous cefuroxime axetil content in cefuroxime axetil crystalline drug substance using modulated differential scanning calorimetry (MDSC)[J].J Chem Pharm Res, 2012, 4(11): 4743-4751.
[28]
LU W, RANTANEN J, YANG M, et al. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying [J].Int J Pharm, 2019, 565: 1-8.
[29]
EDUENG K, BERGSTROM C A S, MAHLIN D, et al.Long-term physical (in)stability of spray-dried amorphous drugs: relationship with glass-forming ability and physicochemical properties [J].Pharmaceutics, 2019, 11(9): 1-4.
[30]
EDINGER M, KNOPP M M, LÖBMANN K, et al.Quantification of microwave-induced amorphization of celecoxib in PVP tablets using transmission Raman spectroscopy [J].Eur J Pharm Sci, 2018, 117: 62-67.
[31]
LUEBBERT C, KLANKE C, SADOWSKI G.Investigating phase separation in amorphous solid dispersions via Raman mapping [J].Int J Pharm, 2018, 535(1/2): 245-252.
[32]
KILPELAINEN T, PAJULA K, KORHONEN O, et al.Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems [J].Eur J Pharm Biopharm, 2020, 155: 49-54.
[33]
CALVO N L, MAGGIO R M, KAUFMAN T S.Chemometrics-assisted solid-state characterization of pharmaceutically relevant materials polymorphic substances[J].J Pharm Biomed Anal, 2018, 147: 518-537.
[34]
GAISFORD S.Isothermal microcalorimetry for quantifying amorphous content inprocessed pharmaceuticals [J].Adv Drug Deliver Rev, 2012, 64(5): 431-439.
[35]
ANGBERG M, NYSTROM C, CASTENSSON S.Evaluation of heat-conduction microcalorimetry in pharmaceutical stability studies.Ⅲ.Crystallographic changes due to water vapour uptake in anhydrous lactose powder [J].Int J Pharm, 1991, 73(3): 209-220.
[36]
ANGBERG M, NYSTROM C, CASTENSSON S.Evaluation of heat conduction microcalorimetry in pharmaceutical stability studies.Ⅴ.A new approach for continuous measurements in abundant water vapour [J].Int J Pharm, 1992, 81(2/3): 153-167.
[37]
ANGBERG M, NYSTROM C, CASTENSSON S.Evaluation of heat-conduction microcalorimetry in pharmaceutical stability studies.Ⅵ.Continuous monitoring of the interaction of water vapour with powders and powder mixtures at various relative humidities [J].Int J Pharm, 1992, 83(1/3): 11-23.
[38]
MACKIN L, ZANON R, DEMONTE M, et al.Quantification of low levels (<10%) of amorphous content in micronised active batches using dynamic vapour sorption and isothermal microcalorimetry [J].Int J Pharm, 2002, 231(2): 227-236.
[39]
STANKOVIC-BRANDL M, ZELLNITZ S, PAUDEL A, et al.The influence of relative humidity and storage conditions on the physico-chemical properties of inhalation grade fine lactose [J].AAPS Pharm Sci Tech, 2021, 23(1): 1.
[40]
MÜLLER T, SCHIEWE J, STECKEL H, et al.Measurement of low amounts of amorphous content in hydrophobicactive pharmaceutical ingredients with dynamic organic vapor sorption [J].Eur J Pharm Sci, 2015, 92: 102-111.
[41]
BAGWAN N U, SHEOKAND S, KUMAR A, et al.Role of surface molecular environment and amorphous content in moisture sorption behavior of milled Terbutaline Sulphate[J].Eur J Pharm Sci, 2021, 161: 105782.
2024年第55卷第2期
25
5
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.02.005
  • 接收时间:2023-05-05
  • 首发时间:2026-11-19
  • 出版时间:2024-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-05-05
基金
作者信息
    1.江西中医药大学药学院,江西 南昌 330004
    2.上海欧米尼医药科技有限公司,上海 201203
    3.南通市海门长三角药物高等研究院,江苏 南通 226133

通讯作者:

王晓飞(1982—),男,高级工程师,博士硕士生导师,从事吸入制剂等复杂制剂的研究与开发。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.02.005
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏